ACE2 and malignant colon neoplasm: Knockdown and overexpression experiments in human colon cancer cells implicated an apparent oncogenic role for ACE2, with pharmacologic BET inhibition recapitulating molecular and phenotypic readouts, including loss of c-Myc, cell growth inhibition, and apoptosis induction.